Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To determine the safety, tolerability, systemic exposure and pharmacokinetics of luliconazole
after repeat daily topical application of Luliconazole Solution, 10% in a maximal use setting
in adults with distal subungual onychomycosis of the toenails.